AIMC Topic: Antineoplastic Agents

Clear Filters Showing 121 to 130 of 592 articles

DRExplainer: Quantifiable interpretability in drug response prediction with directed graph convolutional network.

Artificial intelligence in medicine
Predicting the response of a cancer cell line to a therapeutic drug is pivotal for personalized medicine. Despite numerous deep learning methods that have been developed for drug response prediction, integrating diverse information about biological e...

Evaluating feature extraction in ovarian cancer cell line co-cultures using deep neural networks.

Communications biology
Single-cell image analysis is crucial for studying drug effects on cellular morphology and phenotypic changes. Most studies focus on single cell types, overlooking the complexity of cellular interactions. Here, we establish an analysis pipeline to ex...

Explainable AI-driven prediction of APE1 inhibitors: enhancing cancer therapy with machine learning models and feature importance analysis.

Molecular diversity
The viability of cells and the integrity of the genome depend on the detection and repair of damaged DNA through intricate mechanisms. Cancer treatment employs chemotherapy or radiation therapy to eliminate neoplastic cells by causing substantial dam...

Inhibition of CDC27 O-GlcNAcylation coordinates the antitumor efficacy in multiple myeloma through the autophagy-lysosome pathway.

Acta pharmacologica Sinica
Multiple myeloma (MM) is a prevalent hematologic malignancy characterized by abnormal proliferation of cloned plasma cells. Given the aggressive nature and drug resistance of MM cells, identification of novel genes could provide valuable insights for...

Using mathematical modelling and AI to improve delivery and efficacy of therapies in cancer.

Nature reviews. Cancer
Mathematical modelling has proven to be a valuable tool in predicting the delivery and efficacy of molecular, antibody-based, nano and cellular therapy in solid tumours. Mathematical models based on our understanding of the biological processes at su...

A series of natural language processing for predicting tumor response evaluation and survival curve from electronic health records.

BMC medical informatics and decision making
BACKGROUND: The clinical information housed within unstructured electronic health records (EHRs) has the potential to promote cancer research. The National Cancer Center Hospital (NCCH) is widely recognized as a leading institution for the treatment ...

Use of machine learning algorithms to construct models of symptom burden cluster risk in breast cancer patients undergoing chemotherapy.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
PURPOSE: To develop models using different machine learning algorithms to predict high-risk symptom burden clusters in breast cancer patients undergoing chemotherapy, and to determine an optimal model.

Single-Cell Array Enhanced Cell Damage Recognition Using Artificial Intelligence for Anticancer Drug Discovery.

Analytical chemistry
This work developed a cell damage recognition method based on single-cell arrays using an artificial intelligence tool. The method uses micropatterns (single-cell micropatches and microwells) to isolate each cell in an ordered array to minimize cell ...

Interpretable Dynamic Directed Graph Convolutional Network for Multi-Relational Prediction of Missense Mutation and Drug Response.

IEEE journal of biomedical and health informatics
Tumor heterogeneity presents a significant challenge in predicting drug responses, especially as missense mutations within the same gene can lead to varied outcomes such as drug resistance, enhanced sensitivity, or therapeutic ineffectiveness. These ...

Predicting Clinical Anticancer Drug Response of Patients by Using Domain Alignment and Prototypical Learning.

IEEE journal of biomedical and health informatics
Anticancer drug response prediction is crucial in developing personalized treatment plans for cancer patients. However, High-quality patient anticancer drug response data are scarce and cell line data and patient data have different distributions, mo...